Fifteen years ago, I had a client who changed how I practice.
She was 45 — highly educated, professionally accomplished, and suddenly in crisis. She came to me with a new-onset anxiety and major depression with psychotic features. Over the next nine months, she saw three psychiatrists, was admitted to inpatient care twice (once voluntarily, once not), and worked with multiple mental health providers.
Not one of us mentioned that her symptoms might have a hormonal component.
She did fully recover. But looking back, I can see clearly what none of us saw then: the timing of her breakdown wasn’t incidental. It coincided with the menopausal transition — and the connection between estrogen fluctuation and psychiatric presentation was something we simply hadn’t been trained to recognize.
I wrote about this case and what the research now tells us in a recent piece for ADAA.
You can read the full article here. What I want to do here is go a little deeper on what this means for our daily clinical work.
Why This Keeps Getting Missed
It’s easy to understand how clinicians miss the hormonal connection — not because we’re negligent, but because the symptom overlap is genuinely significant and the stressors are often real and compelling.
My client was navigating her father’s death, her mother’s declining health, her son leaving for college (in a way that felt like rejection), and her husband’s unemployment while she carried the financial weight. Of course we looked there first.
But stress and hormones aren’t mutually exclusive. And the pattern of when symptoms emerge matters. Approximately 50% of the population goes through the menopausal transition, typically beginning in the 40s — sometimes earlier. That window coincides with:
- Increased rates of new-onset depression and anxiety
- Higher rates of antidepressant prescribing
- Greater utilization of mental health services overall
Recent research (Alsugeir et al., 2024) confirms that new psychiatric diagnoses and antidepressant prescriptions cluster significantly during this transition. This isn’t coincidence. It’s biology.
The Overlap Table Worth Memorizing
Here’s the clinical challenge in plain terms:
| Hormonal Change | Psychiatric Presentation |
| Estrogen fluctuation | Anxiety, irritability, panic |
| Estrogen withdrawal | Depressive symptoms |
| Sleep disruption | Mood instability, cognitive impairment |
These aren’t just similar — they can be indistinguishable without a fuller history. And if we’re not asking the right questions, we won’t get the information we need to see the full picture.
What This Means for Our Intake and Assessment
This is the practical shift I’ve made: for any client in their late 30s through 50s presenting with mood or anxiety symptoms, I now routinely ask about:
- Menstrual and reproductive history
- Timing of symptom onset (when exactly did this start?)
- Sleep quality and patterns
- Vasomotor symptoms — hot flashes, night sweats
These aren’t “medical” questions outside our scope. They’re history-taking that helps us conceptualize more accurately. And accurate conceptualization is the foundation of effective treatment.
Moving Beyond the Medical/Mental Health Binary
One of the most important shifts this research has prompted for me is letting go of a false divide. When a 47-year-old woman presents with sudden-onset panic disorder, the question isn’t: is this psychological or hormonal? It’s almost certainly both — and our job is to help her get care that reflects that reality.
That means:
- Normalizing the transition. Many clients don’t know that perimenopause can produce psychiatric symptoms. Psychoeducation here is powerful.
- Collaborating across disciplines. Connecting clients with gynecologists, primary care providers, or menopause specialists isn’t a referral out — it’s a referral alongside.
- Staying current on treatment options. SSRIs and SNRIs remain first-line, but emerging research (Glynne et al., 2025) shows that transdermal estradiol and testosterone therapy can also meaningfully improve mood symptoms. These aren’t decisions we make, but they’re conversations we can open.
The Bottom Line
Estrogen isn’t just a reproductive hormone. It’s a neuroactive regulator with direct implications for mood, cognition, and stress response. When we miss that, we miss something essential about what our clients are experiencing.
I didn’t have this framework 15 years ago. I do now — and so do you. The question is whether we integrate it.
For the full research context and resource list, including The Menopause Society and The Pause Life, read the complete article on ADAA’s site.
